{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02647944","recordId":"NCT02647944","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02647944-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02647944.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02647944.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-01-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-01-05","publishedAt":"2026-08-23","recordId":"NCT02647944","recordSha256":"ce3a23e4791aa7575b4ccc668e87d84fbbd7b4928ea0c627e44312cd9258dc20","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02647944?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-09-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-09-12","publishedAt":"2026-08-23","recordId":"NCT02647944","recordSha256":"880b043e9c83fca4293bcb44f7f290e69b956a9a99ffc134900a0e261738de32","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02647944?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-03-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-03-21","publishedAt":"2026-08-23","recordId":"NCT02647944","recordSha256":"62f9b98a4211003a72f6e662d5d502cc0b2f228df78a72bb61bef3f14cd7644e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02647944?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Eligibility","More Information","Outcome Measures","Outcome Measures (Results)","Oversight","Participant Flow","References","Sponsor/Collaborators","Study Description","Study Identification","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-10-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-10-25","publishedAt":"2026-08-23","recordId":"NCT02647944","recordSha256":"81b2072303f80a418184aadd33b2cd79b0e9fad48102a6dbad34cc58c01bdcd0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02647944?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"1f10d794d65ab05de94e5bfebef7ec8d238b17299d98173fa246e8b82339a6d6"}}